Navigation Links
Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009
Date:10/27/2008

September 30, March 31,

2008 2008

Current assets:

Cash and cash equivalents $34,572 $17,219

Short-term investments 34,998 6,991

Trade receivables, net 21,613 20,873

Inventories, net 17,580 18,657

Prepaid expenses 1,093 427

Net deferred tax asset - current 3,204 2,426

Total current assets 113,060 66,593

Long-term investments - 35,463

Property and equipment, net 14,865 14,599

Intangible assets, net 338 375

Other assets 23 5

Net deferred tax asset - non-current 3,771 3,868

Total assets $132,057 $120,903

Current liabilities:

Accounts payable $4,956 $6,421

Accrued payroll and related expenses 4,231 4,277

Other accrued liabilities 2,312 1,369

Deferred revenue 934 807

Warranty reserve 1,617 1,219

Total current liabilities 14,050 14,093

Non-current liabilities:

Deferred rent 217 286

Deferred revenue 1,439 1,146

Warranty reserve 625 729

Total non-current liabilities 2,281 2,161

'/>"/>
SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
2. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
3. Abaxis to Report Third Quarter Fiscal 2008 Financial Results Thursday, January 31, 2008
4. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
5. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
6. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
7. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
8. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
9. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
10. Aware, Inc. Reports Third Quarter 2008 Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Epeius Biotechnologies Corporation, an emerging leader in ... validation of the cutting-edge science behind its lead ... the world rediscovered the Cyclin G1 gene ... pathogenesis and disease progression, and thus a prime ... NIH National Cancer Institute investigating the role of ...
(Date:12/15/2009)... Dec. 15 Aethlon Medical, Inc. (OTC ... Jeff Schorey and Dr. Wayne Comper ... Sciences, Inc. (ESI). Both Dr. Schorey and Dr. ... ESI, a wholly owned subsidiary of Aethlon Medical, ... the Hemopurifier®, a medical device being advanced as ...
(Date:12/15/2009)... The Center for Business Intelligence ... pleased to announce the full agenda for ... Reporting Congress . The forum will take ... 16-17, 2010. ,, Over 1,500 senior-level Finance, ... this premier event since its inception, and ...
(Date:12/14/2009)... Dec. 14 Array BioPharma Inc. (Nasdaq: ... ) today announced that they entered into an ... small-molecule glucokinase activator program, including ARRY-403, currently being ... patients with Type 2 diabetes. ,, ... receive an upfront payment of $60 million and ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... Oct. 31 Memory,Pharmaceuticals Corp. (Nasdaq: MEMY ... has granted the Company,s request for an,extension until ... Capital Market,minimum market capitalization requirement of $35 million ... equity in order to remain,listed. There can be ...
... ROCKVILLE, Md., Oct. 31 OriGene Technologies, Inc.,announces ... now in,a GFP (green fluorescence protein) vector, enabling ... over 25,000 human ORF,(open reading frame) clones and ... vector., In early October, the 2008 Nobel ...
... 31 SleepQuest has always,followed the essence of its ... and unexplained health problems related to lack of sleep., ... of identifying and treating sleep disorders. Sleep is a,cornerstone ... wellness factor.,Studies done by the National Commission on Sleep ...
Other Biology Technology:Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements 2OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector 2SleepQuest Tireless in Pursuit of Good Sleep 2
(Date:12/16/2009)... 9 BIO-key International, Inc. (OTC ... biometric identification solutions, today announced that SC ... security publications, named BIO-key International the 2009 ... Control sub-category Biometrics. ,, (Logo: ... technology editor, SC Magazine, "Biometric providers have ...
(Date:12/15/2009)... COLUMBIA, Mo. As soon as babies are ... as jaundice and e-coli. For up to a month, ... Although these infections are often minor, they can lead ... newborns, immune systems, University of Missouri researchers have pinpointed ... lead to an immune-strengthening vaccine. , "We,re trying to ...
(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Researchers work on vaccine to improve immune system in newborns 2Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 1Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 2New accurate diagnostic test for swine H1N1 influenza using RT PCR technology 48329 1New accurate diagnostic test for swine H1N1 influenza using RT PCR technology 48329 2European top universities join forces in energy research 8767 1
... Medical Genetics Fellow at The Children,s Hospital in Denver, ... Genzyme/American College of Medical Genetics Foundation (ACMGF) Clinical Genetics ... Clinical Genetics Meeting in Tampa, FL. , The objective ... fellowship program to encourage the recruitment and training of ...
... Montana State University master,s graduate is working with doctors ... handheld laser microscope that could someday reduce the number ... spots on the skin often prompt dermatologists to remove ... best way to diagnose skin cancers, said Chris Arrasmith, ...
... CHAMPAIGN, Ill. Stopping to smell the coffee and ... might do more than just get your juices flowing. It ... , As a former competitive cyclist, University of Illinois kinesiology ... at a coffee shop to fuel up on caffeine prior ...
Other Biology News:Montana State grad's work helps diagnose skin cancer without a biopsy 2Montana State grad's work helps diagnose skin cancer without a biopsy 3A little java makes it easier to jive, researcher says 2A little java makes it easier to jive, researcher says 3A little java makes it easier to jive, researcher says 4
... rapidly and reliably amplify unknown genomic DNA ... provides hassle-free, ready-to use components, at an ... provided in each kit. The Genome Walking ... localized cloning of genomic DNA, isolating promoter ...
... one of the several main MAP kinase ... a sensitive reporter for studying gene regulation ... in sensitivity in comparison to the standard ... the oxidative carboxylation of luciferin, a reaction ...
... Linkage: This CLS number ... created to easily match Cornings ... availability yet, please order under ... or contact customer service for ...
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition...
Biology Products: